Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Aolida Ned Pharmaceutical Co., Ltd. is a commercial-stage Chinese pharmaceutical company founded in 2001 and based in Qing'an County, Heilongjiang Province. As a core enterprise of the Aolida Group, the company integrates scientific research, manufacturing, and marketing of a diverse portfolio of pharmaceuticals. Its manufacturing capabilities cover tablets, hard capsules, granules, and soft capsules, with a strong focus on both small molecule generics and traditional Chinese medicines. Key products include its proprietary allopurinol sustained-release capsules (for gout), amlodipine besylate dispersible tablets (for hypertension), and Hugan Pian (for liver health).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Aolida Neide Pharmaceutical.